Advertisement

When Should a Patient Be Referred to a Mental Health Provider?

  • Brett G. ToelleEmail author
  • Juliet M. Foster
  • Christine R. Jenkins
Part of the Respiratory Medicine book series (RM)

Abstract

Psychological comorbidity in functional respiratory disorders is common and, if not fully appreciated, may lead to inaccurate investigations, treatments, and diagnosis. For this reason, it is important to recognize that comorbid psychological conditions may interact with functional respiratory symptoms for a prolonged period of time without identification by patient or clinician. We propose a model of care that uses screening questions and assessment tools early on in the investigation of the respiratory presentation that uses both patient and clinician time efficiently. A range of simple tools are available for use in primary care to help inform the decision about whether referral to a mental health professional is appropriate. In addition, the severity, age of patient, and/or complexity of the presentation of symptoms are other factors to consider when deciding whether to refer to a mental health ­professional. Many focused psychological strategies can be delivered successfully in primary care, and the ultimate decision about referral will depend on a range of factors including the ability, competence, remuneration, and willingness of primary care staff to deliver these approaches. Because patients with functional respiratory disorders often have a psychological component to their presentation, it is important to address psychological issues in primary care early through treatment strategies or mental health-care referral.

Keywords

Anxiety Depression Mental health Psychological Referral Screening 

References

  1. 1.
    Ellen SR, Norman TR, Burrows GD. MJA practice essentials. 3. Assessment of anxiety and depression in primary care. Med J Aust. 1997;167(6):328–33.PubMedGoogle Scholar
  2. 2.
    Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1): 65–70.PubMedCrossRefGoogle Scholar
  3. 3.
    Lavoie KL, Cartier A, Labrecque M, et al. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? Respir Med. 2005;99(10):1249–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Mitchell EA, Stewart AW, Pattemore PK, Asher MI, Harrison AC, Rea HH. Socioeconomic status in childhood asthma. Int J Epidemiol. 1989;18(4):888–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Stanton AL, Revenson TA, Tennen H. Health psychology: psychological adjustment to chronic disease. Annu Rev Psychol. 2007;58:565–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Thai AL. The effects of health literacy on asthma self-management. J Asthma Allergy Educators. 2010;1:50–5.CrossRefGoogle Scholar
  7. 7.
    Fattahi F, Hylkema MN, Melgert BN, Timens W, Postma DS, ten Hacken NH. Smoking and nonsmoking asthma: differences in clinical outcome and pathogenesis. Expert Rev Respir Med. 2011;5(1):93–105.PubMedCrossRefGoogle Scholar
  8. 8.
    Stommel M, Kurtz ME, Kurtz JC, Given CW, Given BA. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 2004;23(6):564–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Gonzalez-Freire B, Vazquez-Rodriguez I, Marcos-Velazquez P, de la Cuesta CG. Repression and coping styles in asthmatic patients. J Clin Psychol Med Settings. 2010;17(3):220–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax. 2000;55(7):566–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Wright RJ, Rodriguez M, Cohen S. Review of psychosocial stress and asthma: An integrated biopsychosocial approach. Thorax. 1998;53(12):1066–74.PubMedCrossRefGoogle Scholar
  12. 12.
    Barton C, Clarke D, Sulaiman N, Abramson M. Coping as a mediator of psychosocial impediments to optimal management and control of asthma. Respir Med. 2003;97(7):747–61.PubMedCrossRefGoogle Scholar
  13. 13.
    McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J. 2002;19(1):47–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Keele-Card G, Foxall MJ, Barron CR. Loneliness, depression, and social support of patients with COPD and their spouses. Public Health Nurs. 1993;10(4):245–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Fritz GK, Rubinstein S, Lewiston NJ. Psychological factors in fatal childhood asthma. Am J Orthopsychiatry. 1987;57(2):253–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Miller BD, Wood BL, Lim J, Ballow M, Hsu C. Depressed children with asthma evidence increased airway resistance: “vagal bias” as a mechanism? J Allergy Clin Immunol. 009; 124(1):66–73 e61-10.Google Scholar
  17. 17.
    Romagnoli M, Caramori G, Braccioni F, et al. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy. 2007;37(4):552–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax. 1986;41(11):833–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Popa V. Emergency department visits in asthma: Should all be prevented? Chest. 2001;120(4): 1058–61.PubMedCrossRefGoogle Scholar
  20. 20.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Restrepo RD, Peters J. Near-fatal asthma: Recognition and management. Curr Opin Pulm Med. 2008;14(1):13–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest. 2002;121(2):329–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Vazquez I, Sandez E, Gonzalez-Freire B, Romero-Frais E, Blanco-Aparicio M, Verea-Hernando H. The role of alexithymia in quality of life and health care use in asthma. J Asthma. 2010;47(7):797–804.PubMedCrossRefGoogle Scholar
  24. 24.
    Serrano J, Plaza V, Sureda B, et al. Alexithymia: A relevant psychological variable in near-fatal asthma. Eur Respir J. 2006;28(2):296–302.PubMedCrossRefGoogle Scholar
  25. 25.
    Rutgers SR, ten Hacken NH, Koeter GH, Postma DS. Borg scores before and after challenge with adenosine 5′-monophosphate and methacholine in subjects with COPD and asthma. Eur Respir J. 2000;16(3):486–90.PubMedCrossRefGoogle Scholar
  26. 26.
    Ofir D, Laveneziana P, Webb KA, Lam YM, O’Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2008;177(6):622–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Newman KB, Mason 3rd UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1382–6.PubMedGoogle Scholar
  28. 28.
    Thurston NL, Fiedorowicz JG. Improvement of paradoxical vocal cord dysfunction with integrated psychiatric care. Psychosomatics. 2009;50(3):282–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Selner JC, Staudenmayer H, Koepke JW, Harvey R, Christopher K. Vocal cord dysfunction: The importance of psychologic factors and provocation challenge testing. J Allergy Clin Immunol. 1987;79(5):726–33.PubMedCrossRefGoogle Scholar
  30. 30.
    von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007;101(3):411–22.PubMedCrossRefGoogle Scholar
  31. 31.
    Williams Jr JW, Noel PH, Cordes JA, Ramirez G, Pignone M. Is this patient clinically depressed? JAMA. 2002;287(9):1160–70.PubMedCrossRefGoogle Scholar
  32. 32.
    Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: Cross sectional study. BMJ. 2003;327(7424):1144–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–25.PubMedGoogle Scholar
  34. 34.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRefGoogle Scholar
  35. 35.
    Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (dass) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–34.PubMedCrossRefGoogle Scholar
  36. 36.
    Kessler RC, Ustun TB. The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI). Int J Meth Psychiatr Res. 2004;13(2):93–121.CrossRefGoogle Scholar
  37. 37.
    Butani L, O’Connell EJ. Functional respiratory disorders. Ann Allergy Asthma Immunol. 1997;79(2):91–9; quiz 99–101.Google Scholar
  38. 38.
    Ellen SR, et al. Assessing anxiety and depression in primary care. MJA. 1997;167:14–9.Google Scholar
  39. 39.
    van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29(2):199–206.PubMedCrossRefGoogle Scholar
  40. 40.
    Ringsberg KC, Akerlind I. Presence of hyperventilation in patients with asthma-like symptoms but negative asthma test responses: provocation with voluntary hyperventilation and mental stress. J Allergy Clin Immunol. 1999;103(4):601–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ. 2001;322(7294):1098–100.PubMedCrossRefGoogle Scholar
  42. 42.
    Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667–77.PubMedCrossRefGoogle Scholar
  43. 43.
    Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–34.PubMedCrossRefGoogle Scholar
  44. 44.
    Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65(6):963–70.PubMedCrossRefGoogle Scholar
  45. 45.
    Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Resp Med. 2010;104(9):1246–53.CrossRefGoogle Scholar
  46. 46.
    Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur Respir J. 2010;35(3):557–63.PubMedCrossRefGoogle Scholar
  47. 47.
    Raupach T, Bahr F, Herrmann P, et al. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J. 2008;32(2):387–92.PubMedCrossRefGoogle Scholar
  48. 48.
    Cantor L, Jacobson R. COPD: how to manage comorbid depression and anxiety. J Family Pract. 2003;2 www.jfponline.com/Pages.asp?AID=691.

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Brett G. Toelle
    • 1
    Email author
  • Juliet M. Foster
    • 1
  • Christine R. Jenkins
    • 2
    • 3
  1. 1.Respiratory & Environmental Epidemiology GroupWoolcock Institute of Medical ResearchCamperdownAustralia
  2. 2.Co-operative Research Centre for Asthma Woolcock Institute of Medical Research, Thoracic Physician, Concord HospitalUniversity of SydneySydneyAustralia
  3. 3.Department of Thoracic MedicineConcord HospitalConcordAustralia

Personalised recommendations